New study validates high tolerability of Lonza’s immune support ingredient
A new study shows that ResistAid, Lonza’s proprietary immune ingredient, has good tolerability. Conducted by analyze & realize AG, the study interviewed a total of 199 healthy participants, who received either 4.5g ResistAid or placebo for a 12 week period. To examine tolerability based on safety parameters, the research recorded the number of adverse events and changes in various clinical and laboratory parameters, as well as the global evaluation of tolerability by investigators and subjects, as compared to placebo.
Barbara Grube, M.D., coordinating investigator and lead author of the study said,
ResistAid is a natural immune support ingredient extracted from North American larch trees, consisting of larch arabinogalactan and bioactive polyphenols. It has a number of technical properties, which make it formulation-friendly in applications such as dietary supplements and functional foods. ResistAid can be used in standalone form or combined with other products to increase functionality. It is self-affirmed GRAS with notification provided to the U.S. Food and Drug Administration.